Bicara Therapeutics Inc. Contracts & Agreements

15 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Office Lease Agreement, dated August 16, 2023
Lease Agreements
Bicara Therapeutics Inc.
2024
Office Lease Agreement by and between Columbia Property Trust, Inc. and the Registrant, dated as of October 1, 2024
Lease Agreements
Bicara Therapeutics Inc.
2024
Form of Underwriting Agreement
Underwriting Agreements
Bicara Therapeutics Inc.
2024
Specimen Common Stock Certificate
Stock Agreements
Bicara Therapeutics Inc.
2024
Bicara Therapeutics Inc. 2024 Stock Option and Grant Plan and form of award agreements thereunder
Stock Agreements
Bicara Therapeutics Inc.
2024
Bicara Therapeutics Inc. 2024 Employee Stock Purchase Plan
Stock Agreements
Bicara Therapeutics Inc.
2024
Form of Indemnification Agreement by and between the Registrant and each of its directors and executive officers
Indemnification Agreements
Bicara Therapeutics Inc.
2024
Non-Employee Director Compensation Policy
Compensation Agreements
Bicara Therapeutics Inc.
2024
Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated December 6, 2023
Investor Rights Agreements
Bicara Therapeutics Inc.
2024
2019 Stock Option and Grant Plan, as amended, and form of award agreements thereunder
Stock Agreements
Bicara Therapeutics Inc.
2024
Senior Executive Incentive Bonus Plan
Bonus & Incentive Agreements
Bicara Therapeutics Inc.
2024
Form of Executive Employment Agreement
Employment Agreements
Bicara Therapeutics Inc.
2024
Compensation Clawback Policy
Compensation Agreements
Bicara Therapeutics Inc.
2024
Contract Transfer and License Agreement, by and between the Registrant and Biocon Limited, dated October 1, 2019
License Agreements
Bicara Therapeutics Inc.
2024
Clinical Trial Collaboration and Supply Agreement, by and between the Registrant and MSD International GmbH and MSD International Business GmbH, dated May 19, 2022
Collaboration Agreements
Bicara Therapeutics Inc.
2024